The mitochondrial permeability transition pore (mPTP), a high-conductance channel triggered by a sudden Ca concentration increase, is composed of the F F -ATPase. Since mPTP opening leads to mitochondrial dysfunction, which is a feature of many diseases, a great pharmacological challenge is to find mPTP modulators. In our study, the effects of two 1,5-disubstituted 1,2,3-triazole derivatives, five-membered heterocycles with three nitrogen atoms in the ring and capable of forming secondary interactions with proteins, were investigated. Compounds 3a and 3b were selected among a wide range of structurally related compounds because of their chemical properties and effectiveness in preliminary studies. In swine heart mitochondria, both compounds inhibit Ca -activated F F -ATPase without affecting F-ATPase activity sustained by the natural cofactor Mg . The inhibition is mutually exclusive, probably because of their shared enzyme site, and uncompetitive with respect to the ATP substrate, since they only bind to the enzyme-ATP complex. Both compounds show the same inhibition constant (K' ), but compound 3a has a doubled inactivation rate constant compared with compound 3b. Moreover, both compounds desensitize mPTP opening without altering mitochondrial respiration. The results strengthen the link between Ca -activated F F -ATPase and mPTP and suggest that these inhibitors can be pharmacologically exploited to counteract mPTP-related diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/nyas.14474 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!